Neurodegenerative Disease Market Size is valued at 44.51 Billion in 2024 and is predicted to reach 71.67 Billion by the year 2034 at a 5.0% CAGR during the forecast period for 2025-2034. It is anticipated to record a CAGR of 4.3% between 2022 and 2030.An umbrella term for a range of conditions that affect neurons in the human brain are referred to as neurodegenerative diseases. Neurons normally don’t replace or reproduce themselves, so w...
Report ID: 1097 |
Delivery: Immediate |
Published: April 2025 |
No. of Pages: 170
The Antibody Drug Conjugates (ADCs) – Linker and Conjugation Technologies Market size is valued at USD 1.18 Bn in 2024 and is predicted to reach USD 4.06 Bn by the year 2034 at an 13.3% CAGR during the forecast period for 2025-2034. Key Industry Insights & Findings from the Report: Innovations in site-specific conjugation and novel linker chemistries contribute to the development of more effective and reliable ADCs. Colla...
Report ID: 1179 |
Delivery: Immediate |
Published: April 2025 |
No. of Pages: 190
Global Dark Genome Therapeutics Market Size is valued at USD 2.6 Bn in 2024 and is predicted to reach USD 15.7 Bn by the year 2034 at a 20.3% CAGR during the forecast period for 2025-2034. The dark genome comprises long stretches of DNA, including genes that encode conventional proteins as well as a vast array of genomic repeats, repeating elements that dominate this non-coding portion of the genome. Many of these repeats originated from ancient...
Report ID: 2995 |
Delivery: Immediate |
Published: April 2025 |
No. of Pages: 180
T-cell Engagers Market Size is predicted to grow at a 31.6% CAGR during the forecast period for 2025-2034. T-cell engagers are a class of engineered antibodies designed to recognize and eliminate harmful cells, such as tumor cells in cancer or autoreactive cells in autoimmune diseases. They work by binding simultaneously to a specific antigen on the target cell and the Cluster of Differentiation 3 (CD3) receptor on T cells, bringing them into ...
Report ID: 3002 |
Delivery: Immediate |
Published: April 2025 |
No. of Pages: 180
Global SERD Therapeutics Market Size is valued at USD 1339.0 Mn in 2024 and is predicted to reach USD 2108.7 Mn by the year 2034 at a 4.8% CAGR during the forecast period for 2025-2034. Selective estrogen receptor degrader (SERD) is a type of drug which downregulates the estrogen receptor. SERD treats estrogen receptor-positive breast cancer. SERD therapy can be used as both monotherapies and in combination with other therapeutic agents. Many ke...
Report ID: 1246 |
Delivery: Immediate |
Published: April 2025 |
No. of Pages: 180
Global Keloid Treatment Market Size is valued at USD 3.7 Bn in 2024 and is predicted to reach USD 5.1 Bn by the year 2034 at a 3.4% CAGR during the forecast period for 2025-2034. Keloid management often requires a combination of treatments and prevention strategies, such as minimizing skin trauma and using silicone products, which may also play a role in reducing keloid formation and recurrence. Keloids are thickened formations of fibrous tissue...
Report ID: 2058 |
Delivery: Immediate |
Published: April 2025 |
No. of Pages: 180
Social Determinants of the Health Market Size is valued at USD 6.56 Bn in 2024 and is predicted to reach USD 33.84 Bn by the year 2034 at a 17.9% CAGR during the forecast period for 2025-2034. Social determinants of health are the environmental conditions of people that affect their health, well-being, and quality of life. Financial security, education, healthcare, neighborhood and built environment safety, and social and community networks ar...
Report ID: 2359 |
Delivery: Immediate |
Published: April 2025 |
No. of Pages: 180
Global Nanomedicine Market Size is valued at USD 213.4 Bn in 2024 and is predicted to reach USD 655.4 Bn by the year 2034 at a 12.0% CAGR during the forecast period for 2025-2034. Key Industry Insights & Findings from the Report: Technological developments in areas like early illness diagnosis, chronic disease prevention, and preventative intervention are propelling the growth of the nanomedicine industry. Rising sophisticated drug deliv...
Report ID: 1889 |
Delivery: Immediate |
Published: April 2025 |
No. of Pages: 180
Global Lipid Nanoparticles (LNPs) CDMO Market Size is valued at USD 205.4 Mn in 2024 and is predicted to reach USD 803.6 Mn by the year 2034 at a 14.8% CAGR during the forecast period for 2025-2034. Key Industry Insights & Findings from the Report: The advent of LNPs is aroused due to a high prevalence of infectious diseases, rising healthcare expenditures, and medical applications of nanoparticles. The increasing demand for ...
Report ID: 1432 |
Delivery: Immediate |
Published: April 2025 |
No. of Pages: 190
Global ADC Payload / Warheads Market Size is valued at USD 298.4 Mn in 2024 and is predicted to reach USD 736.7 Mn by the year 2034 at a 9.8% CAGR during the forecast period for 2025-2034. Antibody-drug conjugates (ADCs) represent one of the fastest-growing classes of anticancer therapies, offering a targeted approach that enhances efficacy while minimizing systemic toxicity. By chemically linking a cytotoxic payload to a monoclonal antibody (mA...
Report ID: 2990 |
Delivery: Immediate |
Published: April 2025 |
No. of Pages: 180
Pharmaceuticals